STOCK TITAN

Reliance Global Group, Inc. 424B Filings

EZRA NASDAQ

Every 424B that Reliance Global Group, Inc. (EZRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow EZRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EZRA filings page.

Rhea-AI Summary

Reliance Global Group, Inc. registered up to 16,107,568 additional common shares for resale by White Lion Capital, LLC. Shares may be issued to White Lion under the company’s discretionary equity line; Reliance receives no proceeds from White Lion’s resales. The registered amount represents approximately 959% of the 1,679,936 common shares outstanding as of August 26, 2026.

The amended equity-line commitment is $50.0 million. Through August 31, 2026, Reliance had sold approximately $1.6 million of shares under the agreement, leaving approximately $48.4 million available; future sales to White Lion could generate up to approximately $48.4 million in gross proceeds after the registration statement becomes effective. The company chooses whether and how much to sell, subject to agreement terms. Standard notices use the lowest traded price during a three-hour period beginning upon written acknowledgment; with White Lion’s consent, fixed notices price shares at 90% of the lowest traded price during the preceding five-minute period. Shares issued to White Lion increase shares outstanding and dilute existing holders.

Rhea-AI Summary

Reliance Global Group, Inc. filed a post-effective prospectus supplement updating its registration to cover the securities issued in its January 29, 2026 public financing and the ongoing issuance of shares upon exercise of related warrants. The January 2026 Offering sold 7,219,259 shares, 188,149 pre-funded warrants, 14,814,816 common warrants and issued 518,519 placement agent warrants at a combined public offering price of $0.27 per unit (or $0.269 per pre-funded unit), generating gross proceeds of approximately $2.0 million. The prospectus registers up to 15,521,484 shares issuable upon exercise of the issued warrants, and summarizes exercise terms (common warrant exercise price $0.27, pre-funded warrant exercise price $0.001, placement agent warrant exercise price $0.3375) and related transfer, beneficial-ownership limitations and cashless-exercise provisions.

The filing also discloses recent corporate developments including the launch of EZRA International/Scale51, a staged equity investment in Enquantum (16% ownership to date, target 51% via milestone tranches), amendments expanding an equity line commitment to $50.0 million, repayment of approximately $5.0 million of long-term debt in 2025, adoption of a digital asset treasury strategy, and corporate governance updates (restated articles and amended bylaws). The company’s Nasdaq ticker changed to EZRA and the last reported sale price on April 28, 2026 was $0.1753 per share.

Rhea-AI Summary

Reliance Global Group, Inc. is amending its existing prospectus supplement to increase the maximum capacity of its at-the-market stock offering. The company may now offer and sell shares of its common stock with an aggregate offering price of up to $1,764,443 from time to time through or to H.C. Wainwright & Co. as sales agent or principal. This limit is set under Form S-3 rules that cap primary offerings at one-third of the public float while the float remains below $75.0 million. As of February 5, 2026, the public float was approximately $12,324,310, based on 16,795,190 shares held by non-affiliates and a last reported sale price of $0.7338 per share, and the company has already sold $2,343,660 of shares under these constraints in the prior 12 months.